Sarah E. Dunsmore, Ph.D., highlights the importance of technology and NCATS’ ability to share data during the pandemic. In addition to her current role at NCATS, Dr. Dunsmore also serves as the project manager for ACTIV-6, which aims to provide evidence-based treatment options for the majority of adults with COVID-19 who have mild to moderate symptoms and are not sick enough to be hospitalized. She explains how the initiative is unique compared to the other ACTIV trials, which focus more on the severe effects of COVID-19. #IAmTranslationalScience

Learn more about NCATS' role in ACTIV: [ Ссылка ]

A version of this video with audio description is available: [ Ссылка ]

свернуть